Novo adds to Wegovy’s cardio strength with hospital admissions analysis

SAN ANTONIO — Novo Nordisk’s wildly popular anti-obesity drug Wegovy helped heart disease patients end up in the hospital less often and stay there for shorter durations than those on placebo, according to a new ...